New hope for severe brain cancer: drug combo shrinks tumors before radiation
NCT ID NCT03623347
First seen Jun 18, 2026 · Last updated Jun 18, 2026
Summary
This study tested a new treatment plan for people with a severe type of brain cancer called glioblastoma who are too sick for standard radiation. Doctors gave a combination of two drugs, bevacizumab and temozolomide, first to shrink the tumor and improve symptoms. The goal was to see if this approach could make radiation therapy possible later. The study included 70 adults with advanced disease and aimed to improve their quality of life and survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMORADIOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Amiens-Picardie
Amiens, 80054, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.